Cell Culture Human hepatocarcinoma HepG2 cells were obtained from the Japanese Cancer Research Resources Bank (Tokyo, Japan). The HepG2 cells and GnT-III gene transfectants were cultured in DMEM supplemented with 10% FCS and 0.1 mg/ml of ampicillin under a humidified atmosphere of 95% air and 5% CO 2 . Following incubation for 1 d with serum-free DMEM, the cells were incubated with 50 ng/ml of HGF in serum-free DMEM.
Expression Vector Construct, Gene Transfection, and Selection of Cells The human GnT-III cDNA was amplified by PCR using human brain cDNA as a template. The cDNA fragment containing the entire coding sequence was inserted into the pCI-neo EcoR I site and the final construct, pCI-GnT-III, was obtained. The pCI-neo is a mammalian expression vector which includes the cytomegalovirus enhancer/promoter and the G418-resistant gene. HepG2 cells were plated in a 6-cm plastic culture dish at a density of 1ϫ10 6 cells/ml. After 24 h, the cells were washed twice with ice-cold phosphate-buffered saline (PBS), pH 7.2, and the medium was changed to serum-free Opti-MEM. The pCIGnT-III vector or pCI-neo vector (20 mg) was mixed with Lipofectamine plus, 100 ml of which was added to the HepG2 cells. After 5 h incubation, the medium was changed to DMEM supplemented with 10% FCS. Stable transfectants were selected using 1 mg/ml G418.
GnT-III Activity The GnT-III activity was measured according to the methods described previously.
11) Briefly, cell pellets were homogenized in ice-cold PBS containing protease inhibitors, and the supernatant was obtained after removal of the nucleus fraction by centrifugation for 20 min at 900ϫg. The GnT-III activity in the supernatant was assayed by high performance liquid chromatography methods using the fluorescence-labeled sugar chain (GlcNAcb-1, 2-Mana-1, 6-[GlcNAcb-1, 2-Mana-1, 3-] Manb-1, 4-GlcNAcb-1, 4-GlcNAc-pyridylamino) as a substrate. The substrate was prepared according to the method of Tokugawa et al.
12)
Cell Scattering Assay The HepG2 cells were plated in a 6-cm plastic culture dish at a density of 5ϫ10 4 cells/ml. The HepG2 cells were allowed to grow as discrete colonies for 2-3 d. The culture medium was then replaced with fresh DMEM medium containing 50 ng/ml HGF. After 24 h, the cells were observed under a phase contrast microscope.
Immunoprecipitation and Western Blot Analysis The cultured cells were washed twice with ice-cold PBS and disrupted in the lysis buffer (20 mM Tris, pH 7.2, 1% Triton X-100, 10% glycerol, 1 mM APMSF, 5 mM aprotinin, 1 mM sodium orthovanadate, 10 mM sodium fluoride, and 10 mM iodoacetamide). The protein concentrations were determined using a protein assay kit (Bio-Rad, CA, U.S.A.). The cell-free lysates (1 mg) were immunoprecipitated with the anti-human c-Met antibody and protein G-immobilized magnetic beads (BioMag Protein G). For Western blot analysis, whole cell lysates or immunoprecipitates were subjected to 6 or 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) under reducing conditions, and then transferred to a PVDF membrane. The blot was blocked with 1% bovine serum albumin (BSA) in Tris-buffered saline containing 0.1% Tween 20 (TBST). For the detection of c-Met, the blot was incubated with anti-human c-Met antibody, and biotinylated anti-rabbit IgG antibody. For the detection of the phosphorylated tyrosine residues of c-Met, the blot was incubated with a monoclonal anti-phosphotyrosine antibody, and peroxidase-conjugated rabbit anti-mouse IgG. For the detection of phosphorylated ERK1/2, the blot was incubated with anti-ERK antibody, and biotinylated anti-mouse IgG antibody. Biotinylated antibody was detected using a Vectastain ABC-kit, and the blots were developed using the ECL chemiluminescence detection kit according to the manufacturer's instructions.
Lectin Blot Analysis Immunoprecipitated c-Met were subjected to 6% SDS-PAGE and transferred to PVDF membranes, as described above. The blot was blocked with 1% BSA in TBST and then incubated with 1 mg/ml biotinylated erythroagglutinating phytohemagglutinin (E-PHA) in TBST for 1 h at room temperature. After washing with TBST, the lectin-reactive proteins were detected using a Vectastain ABC kit and the ECL chemiluminescence detection kit.
RESULTS

Establishment of HepG2 Cell Lines Stably Expressing
GnT-III The GnT-III expression vector pCI-GnT-III was transfected into the HepG2 cells. The G418-resistant cells were screened as candidates of the GnT-III transfectants. Two randomly selected G418-resistant clones were evaluated for GnT-III activity. The clones expressing moderately and highly were designated HepG2-IIIm and HepG2-IIIh, respectively. A pCI-neo vector transfectant, designated as HepG2-mock, was also established as a negative control. The GnT-III activity in the HepG2-IIIm and HepG2-IIIh cells was significantly elevated about 20-and 250-fold, respectively, whereas the activity in the HepG2-mock cells did not differ significantly among the parental HepG2 cells (Table 1) .
Enhancement of HGF-Induced Cell Scattering in GnT-III Transfectants To determine the effect of the overexpression of GnT-III on the HGF-induced cell scattering, the GnT-III transfectants and mock transfectants were examined. When the HepG2-mock cells were cultured, they showed a cobble-stone shape and had formed colonies of the cells (Fig.  1A) . No significant difference in cell morphology of the GnT-III transfectants was observed (Figs. 1B, C) . HepG2-mock cells scattered following cell-cell dissociation by the stimulation with HGF (Fig. 1D) . The cell scattering of the GnT-III transfectants was more pronounced than the HepG2-mock cells; the enhancement of cell scattering was most pronounced in the HepG2-IIIh cells that had a high GnT-III activity (Figs. 1E, F) .
Analysis of c-Met of GnT-III Transfectants
The expression levels of the c-Met protein in GnT-III transfectants were analyzed by Western blot analysis. No significant change of the level of c-Met was observed (Fig. 2) . To analyze the alterations of the N-glycan structure on c-Met, E- PHA lectin blot analysis was performed. E-PHA binds specifically to bisecting GlcNAc residues. 13) Immunoprecipitated c-Met from the HepG2-IIIm cells and the HepG2-IIIh cells showed significant reactivity of E-PHA (Fig. 3) , showing that N-glycan on c-Met was modified with bisecting GlcNAc residues. It was noted that the apparent molecular size of c-Met from the HepG2-IIIh cells were smaller than that from the HepG2-mock cells. The following experiments were performed with HepG2-IIIh cells and HepG2-mock cells.
Tyrosine Phosphorylation of c-Met in Gn T-III Transfectants To determine the effect of the GnT-III transfection on HGF signaling, HGF-induced tyrosine phosphorylation of c-Met in HepG2-IIIh cells and HepG2-mock cells were examined. The c-Met phosphorylation level reached a peak by 10 min after the HGF treatment in each transfectant. Although no difference in the peak level of c-Met phosphorylation between the HepG2-IIIh cells and HepG2-mock cells was observed, the level of c-Met phosphorylation in the HepG2-IIIh cells was reduced more rapidly than in the HepG2-mock cells (Fig. 4) .
ERK Activation in GnT-III Transfectants
To further clarify the effect of the GnT-III transfection on HGF signaling, the HGF-induced phosphorylation of ERK in the HepG2-IIIh cells and HepG2-mock cells was also examined. The time course of the tyrosine phosphorylation of ERK showed that the phosphorylated ERK level reached a peak by 10 min after treatment in each transfectant. The peak level in the HepG2-IIIh cells was slightly higher than in the HepG2-mock cells (Fig. 5) .
DISCUSSION
In this paper we investigated the effects of the overexpression of GnT-III on the scattering of human hepatocarcinoma HepG2 cells, a defined HGF-induced biological response, since the function of the HGF receptor c-Met could be modulated by GnT-III transfection followed by the alteration of its biological functions, as described in the "INTRODUC-TION" section. The results showed that GnT-III gene transfection increases GnT-III activity by about 250 fold, followed by a significant increase of E-PHA reactivity with c-Met (Fig. 3) , indicating that the transfection of GnT-III increased the amount of bisecting oligosaccharide residue on c-Met. In addition, the molecular size of c-Met in the HepG2-IIIh cells was smaller than that in the HepG2-mock cells (Figs. 2, 3) , suggesting that an elongation of N-glycans on c-Met was suppressed by the bisecting GlcNAc residue. The same observation has been shown in various glycoproteins such as the EGF receptor, 7) E-cadherin, 14, 15) and CD44. 16) We investigated the effect of the overexpression of GnT-III on HGF-induced cell scattering using these transfectants, because cell scattering is one of the HGF-induced biological responses and an important component of several physiological and pathological processes. We found that HGF-induced cell scattering in the GnT-III transfectants was enhanced depending on the GnT-III activities. As far as we know, this is the first report of the enhancing effect of HGF-induced cell scattering by the overexpression of GnT-III.
To confirm the effect of GnT-III overexpression on HGF signaling, we first investigated the effect on the HGF-induced tyrosine phosphorylation of c-Met in GnT-III transfectants. Unexpectedly, the peak level of the tyrosine phosphorylation of c-Met did not change by GnT-III. In addition, the level of c-Met phosphorylation was reduced quite a bit more rapidly than that in the HepG2-mock cells. Previous studies shown that HGF stimulation also leads to down-regulation of the receptor. 17) We assume that the rapid dephosphorylation was caused by up-regulated HGF signaling.
We further examined the effects on the HGF-induced phosphorylation of ERK, because ERK activation is associated with HGF-induced cell scattering.
18) The ERK phosphorylation was slightly enhanced by the GnT-III overexpression, showing that the enhancement of cell scattering involves the up-regulation of the HGF-induced ERK phosphorylation. The mechanisms by which GnT-III overexpression affects ERK activation is now under investigation. It has been shown that GnT-III overexpression enhances the EGF-induced ERK phosphorylation in HelaS3 cells by up-regulation of the internalization rate of the receptors. 7) A possible mechanism by which GnT-III overexpression enhances HGF-induced ERK phosphorylation is that GnT-III affects c-Met internalization.
In this study, we demonstrated that GnT-III overexpression increased the amount of bisecting oligosaccharide structures and shortened the N-glycans associated with c-Met. Lectin blot analysis of total showed that N-glycans of the other glycoproteins were also changed by GnT-III overexpression (data not shown). Therefore, the glycoproteins involved in cell scattering, such as E-cadherin and integrin, are candidate proteins for involvement in the enhancement of cell scattering by GnT-III overexpression. In fact, it has been reported that GnT-III overexpression affects their biological functions. 14, 15, 19) Further study is needed to clarify the mechanism involved in the enhancement of cell scattering.
In evaluating the significance of the present results, it seems worthwhile to examine the relation of the change of GnT-III with the action of HGF in vivo. In the normal rat liver, GnT-III activity is very low. However, the activity increased about 4-fold in regenerating rat liver. 9) HGF is induced in regenerating rat liver, and stimulates hepatocyte growth. In addition, it was shown that hepatocarcinoma exhibited a high level of GnT-III activity, whereas normal liver contains very little. 20) Autocrine HGF signaling leads to abnormal malignant progression. 21) Therefore, the increase of GnT-III may contribute to liver regeneration and hepatocarcinoma progression by the enhanced HGF signal.
In conclusion, we demonstrated that the overexpression of GnT-III caused the enhancement of HGF-induced cell scattering, and suggest that the enhancement of cell scattering involves, at least in part, enhancement of the HGF-induced ERK phosphorylation. 
